Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal fentanyl sedation for remifentanil weaning during mechanical ventilation
2019-002509-22Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in critical illness comparing Transdermal fentanyl intervention with Remifentanil control (2 arms). Primary endpoint: Area under the curve of work of breathing per minute at 72 hours. Started May 2021; status: completed.
02
Drugs
fentanylremifentanil
03
Conditions
critical illness
Beyond the preview
Go deeper on 2019-002509-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002509-22.